PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$1.15
0.00 (0.00%)
▲
5d:
-2.95%
30d:
-22.82%
90d:
-4.96%
HOLD
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PACB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PACB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.23 to $1.53.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.07, while resistance sits at $1.47.
Market Sentiment: PACB scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.29 (+99.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.07, while resistance sits at $1.47.
Market Sentiment: PACB scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.29 (+99.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.23 -
$1.53
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding PACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 99.3% below Wall St target ($2.29)
- CAUTION: Bottoming setup, but lagging the sector by 26% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.23 -
$1.53
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.07
Resistance Level
$1.47
Current Trend
Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.89
Wall Street Target
$2.29
(+99.3%)
Revenue Growth (YoY)
-1.9%
Profit Margin
-82.5%
Share & Embed Analysis
Last updated: August 15, 2026 8:01 PM ET
Data refreshes hourly during market hours. Next update: 9:01 PM
Data refreshes hourly during market hours. Next update: 9:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Christian O Henry
SELL
12497 shares
2026-03-03
Michele Farmer
SELL
2979 shares
2026-03-03
Oene Mark Van
SELL
6504 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 33 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$382 | 48 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 28 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 41 HOLD |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
